Skip to main content
. Author manuscript; available in PMC: 2019 Aug 16.
Published in final edited form as: Pituitary. 2019 Feb;22(1):37–45. doi: 10.1007/s11102-018-0924-0

Fig. 1.

Fig. 1

Gadolinium-based contrast agents (GBCAs) consist of a central paramagnetic Gadolinium (Gd 3+) chelated to a ligand, preventing direct toxicity from free Gd3+. The biochemical structure of the types of ligands are illustrated: a Linear agents, with an elongated organic molecular ligand wrapping around the ion and b Macrocyclic agents, which form a cage-like ligand structure with the ion trapped in the central cavity